TGFB1 and non-small cell lung carcinoma: The inhibition of TGFβRII by YAP/TAZ, through both transcriptional and post‐transcriptional methods, along with research indicating that an increase in TGFβRII expression could improve TGF‐β sensitivity and reduce lung tumor growth in both NSCLC and small‐cell lung cancer (SCLC) cell lines, underscores the complexity of these pathways [204].